Aemetis (AMTX) 10-Q 7 Nov 22 2022 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Oct. 31, 2022
Document Information [Line Items]
Entity Central Index Key	0000738214
Entity Registrant Name	AEMETIS, INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-36475
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1407544
Entity Address, Address Line One	20400 Stevens Creek Blvd., Suite 700
Entity Address, City or Town	Cupertino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95014
City Area Code	408
Local Phone Number	213-0940
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	AMTX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		35,043,877

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 251	$ 7,751
Accounts receivable, net of allowance for doubtful accounts of $0 and $1,404 as of September 30, 2022 and December 31, 2021, respectively	9,127	1,574
Inventories, net of allowance for excess and obsolete inventory of $1,040 as of September 30, 2022 and December 31, 2021, respectively	10,431	5,126
Prepaid expenses	3,671	5,598
Other current assets	571	644
Total current assets	24,051	20,693
Property, plant and equipment, net	169,485	135,101
Operating lease right-of-use assets	2,227	2,462
Other assets	3,112	2,575
Total assets	198,875	160,831
Current liabilities:
Accounts payable	32,938	16,415
Current portion of long term debt	10,204	8,192
Short term borrowings	18,816	14,586
Accrued property taxes	1,028	6,830
Accrued contingent litigation fees	0	6,200
Current portion of operating lease liability	267	260
Other current liabilities	6,448	5,872
Total current liabilities	183,094	65,330
Long term liabilities:
Senior secured notes and revolving notes	151,086	121,451
EB-5 notes	31,000	32,500
Other long term debt	11,876	12,038
Operating lease liability	2,120	2,318
Other long term liabilities	4,589	2,454
Total long term liabilities	200,671	215,739
Stockholders' deficit:
Common stock, $0.001 par value; 80,000 authorized; 35,043 and 33,461 shares issued and outstanding each period, respectively	35	33
Additional paid-in capital	226,883	205,305
Accumulated deficit	(406,575)	(321,227)
Accumulated other comprehensive loss	(5,234)	(4,350)
Total stockholders' deficit	(184,890)	(120,238)
Total liabilities and stockholders' deficit	198,875	160,831
Series B Convertible Preferred Stock [Member]
Stockholders' deficit:
Series B convertible preferred stock, $0.001 par value; 7,235 authorized; 1,270 and 1,275 shares issued and outstanding each period, respectively (aggregate liquidation preference of $3,810 and $3,825 respectively)	1	1
Convertible Series B Preferred Stock Subject to Mandatory Redemption [Member]
Current liabilities:
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current	3,992	3,806
Long term liabilities:
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	0	44,978
Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Current liabilities:
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current	$ 109,401	$ 3,169

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Cash and cash equivalents	$ 251	$ 7,751
Allowance For Doubtful Accounts	0	1,404
Inventory Valuation Reserves	1,040	1,040
Prepaid expenses	3,671	5,598
Property, plant and equipment, net	169,485	135,101
Operating lease right-of-use assets	2,227	2,462
Other assets	3,112	2,575
Accounts payable	32,938	16,415
Short term borrowings	18,816	14,586
Accrued property taxes	1,028	6,830
Current portion of operating lease liability	267	260
Other current liabilities	6,448	5,872
Other long term debt	$ 11,876	$ 12,038
Common Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized (in shares)	80,000	80,000
Common Stock, Shares Issued (in shares)	35,043	33,461
Common Stock, Shares Outstanding (in shares)	35,043	33,461
Series B Convertible Preferred Stock [Member]
Series B Preferred Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Series B Preferred Stock, Authorized (in shares)	7,235	7,235
Series B Preferred Stock, Shares Issued (in shares)	1,270	1,275
Series B Preferred Stock, Shares Outstanding (in shares)	1,270	1,275
Aggregate Liquidation Preference	$ 3,810	$ 3,825
Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current	109,401	3,169
Convertible Series B Preferred Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current	3,992	3,806
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	0	44,978
Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents	0	19
Prepaid expenses	223	335
Property, plant and equipment, net	63,961	39,625
Operating lease right-of-use assets	0	10
Other assets	584	38
Accounts payable	11,545	4,950
Short term borrowings	9	9
Accrued property taxes	0	121
Current portion of operating lease liability	6	11
Other current liabilities	442	306
Other long term debt	33	40
Variable Interest Entity, Primary Beneficiary [Member] | Convertible Series B Preferred Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	$ 0	$ 44,978

Consolidated Condensed Statemen

Consolidated Condensed Statements of Operations and Comprehensive (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 71,831	$ 49,895	$ 189,781	$ 147,586
Cost of goods sold	72,935	54,680	194,184	152,333
Gross profit (loss)	(1,104)	(4,785)	(4,403)	(4,747)
Research and development expenses	52	22	139	66
Selling, general and administrative expenses	6,867	5,087	21,234	16,222
Other operating (income)	(428)	0	(68)	0
Operating loss	(7,595)	(9,894)	(25,708)	(21,035)
Interest expense
Interest rate expense	5,456	4,408	14,819	14,902
Debt related fees and amortization expense	1,633	1,140	5,199	3,045
Accretion and other expenses of Series A preferred units	2,774	2,185	5,920	7,928
Loss (gain) on debt extinguishment	49,386	0	49,386	(1,134)
Gain on litigation	0	0	(1,400)	0
Other (income) expense	(2)	(30)	(14,297)	483
Loss before income taxes	(66,842)	(17,597)	(85,335)	(46,259)
Income tax expense	3	0	13	7
Net loss	(66,845)	(17,597)	(85,348)	(46,266)
Other comprehensive loss
Foreign currency translation loss	(300)	22	(884)	(187)
Comprehensive loss	$ (67,145)	$ (17,575)	$ (86,232)	$ (46,453)
Net loss per common share
Basic (in dollars per share)	$ (1.92)	$ (0.55)	$ (2.49)	$ (1.55)
Diluted (in dollars per share)	$ (1.92)	$ (0.55)	$ (2.49)	$ (1.55)
Weighted average shares outstanding
Basic (in shares)	34,769	31,857	34,344	29,818
Diluted (in shares)	34,769	31,857	34,344	29,818

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net loss	$ (85,348)	$ (46,266)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation	4,934	1,401
Depreciation	4,039	4,106
Debt related fees and amortization expense	5,199	3,045
Intangibles and other amortization expense	35	35
Accretion and other expenses of Series A preferred units	5,920	7,928
Loss on asset disposals	47	0
Loss (gain) on debt extinguishment	49,386	(1,134)
Gain on litigation	(1,400)	0
Loss on lease termination	736	0
Provision for bad debts	0	144
Changes in operating assets and liabilities:
Accounts receivable	(7,987)	50
Inventories	(5,639)	(902)
Prepaid expenses	2,786	(2,847)
Other assets	(505)	2,475
Accounts payable	8,754	(4,624)
Accrued interest expense and fees	12,801	9,256
Other liabilities	(10,065)	7,340
Net cash used in operating activities	(16,307)	(19,993)
Investing activities:
Capital expenditures	(28,931)	(18,771)
Grant proceeds and other reimbursements received for capital expenditures	7,401	1,224
Net cash used in investing activities	(21,530)	(17,547)
Financing activities:
Proceeds from borrowings	39,860	0
Repayments of borrowings	(16,191)	(53,523)
Lender debt renewal and waiver fee payments	(1,169)	(1,008)
Grant proceeds received for capital expenditures	0	115
Payments on finance leases	(314)	(373)
Proceeds from issuance of common stock in equity offering	7,996	94,203
Proceeds from the exercise of stock options	206	1,104
Proceeds from Series A preferred units financing	0	3,130
Series A preferred financing redemption	0	(300)
Net cash provided by financing activities	30,388	43,348
Effect of exchange rate changes on cash and cash equivalents	(51)	(11)
Net change in cash and cash equivalents for period	(7,500)	5,797
Cash and cash equivalents at beginning of period	7,751	592
Cash and cash equivalents at end of period	251	6,389
Supplemental disclosures of cash flow information, cash paid:
Cash paid for interest	15,476	5,646
Income taxes paid	10	7
Supplemental disclosures of cash flow information, non-cash transactions:
Subordinated debt extension fees added to debt	680	680
Debt fees added to revolving lines	800	0
Fair value of warrants issued to subordinated debt holders	1,939	1,546
Fair value of warrants issued for guarantee fees	2,012	0
Fair value of warrants issued to lender for debt issuance costs	3,158	0
Fair value of stock issued to lender	1,335	0
Lender debt extension, waiver, and other fees added to debt	583	608
Capital expenditures in accounts payable	15,957	4,695
Payment of debt added to revolving lines	16,266	0
Financing lease liabilities arising from obtaining right of use assets	2,932	113
Capital expenditures purchased on financing	290	55
Issuance of equity to pay off accounts payable	$ 0	$ 893

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2020	1,323	22,830
Balance at Dec. 31, 2020	$ 1	$ 23	$ 93,426	$ (274,080)	$ (4,114)	$ (184,744)
Issuance of common stock (in shares)	0	5,682
Issuance of common stock	$ 0	$ 6	62,389	0	0	62,395
Stock options exercised (in shares)	0	1,226
Stock options exercised	$ 0	$ 1	1,002	0	0	1,003
Stock-based compensation	$ 0	$ 0	835	0	0	835
Issuance and exercise of warrants (in shares)	0	113
Issuance and exercise of warrants	$ 0	$ 0	281	0	0	281
Net loss	0	0	0	(18,112)	0	(18,112)
Foreign currency translation gain (loss)	$ 0	$ 0	0	0	(25)	(25)
Balance (in shares) at Mar. 31, 2021	1,323	29,851
Balance at Mar. 31, 2021	$ 1	$ 30	157,933	(292,192)	(4,139)	(138,367)
Balance (in shares) at Dec. 31, 2020	1,323	22,830
Balance at Dec. 31, 2020	$ 1	$ 23	93,426	(274,080)	(4,114)	(184,744)
Foreign currency translation gain (loss)						(187)
Net loss						(46,266)
Balance (in shares) at Sep. 30, 2021	1,285	32,564
Balance at Sep. 30, 2021	$ 1	$ 33	192,520	(320,346)	(4,301)	(132,093)
Balance (in shares) at Mar. 31, 2021	1,323	29,851
Balance at Mar. 31, 2021	$ 1	$ 30	157,933	(292,192)	(4,139)	(138,367)
Issuance of common stock (in shares)	0	976
Issuance of common stock	$ 0	$ 1	24,773	0	0	24,774
Stock options exercised (in shares)	0	745
Stock options exercised	$ 0	$ 1	28	0	0	29
Stock-based compensation	0	0	281	0	0	281
Foreign currency translation gain (loss)	0	0	0	0	(184)	(184)
Net loss	$ 0	$ 0	0	(10,557)	0	(10,557)
Balance (in shares) at Jun. 30, 2021	1,323	31,572
Balance at Jun. 30, 2021	$ 1	$ 32	183,015	(302,749)	(4,323)	(124,024)
Issuance of common stock (in shares)	0	576
Issuance of common stock	$ 0	$ 1	7,883	0	0	7,884
Series B conversion to common stock (in shares)	(38)
Series B conversion to common stock	$ 0	$ 0	0	0	0	0
Series B conversion to common stock, Shares Issued (in shares)		4
Stock options exercised (in shares)	0	299
Stock options exercised	$ 0	$ 0	72	0	0	72
Stock-based compensation	$ 0	$ 0	285	0	0	285
Issuance and exercise of warrants (in shares)	0	113
Issuance and exercise of warrants	$ 0	$ 0	1,265	0	0	1,265
Foreign currency translation gain (loss)	0	0	0	0	22	22
Net loss	$ 0	$ 0	0	(17,597)	0	(17,597)
Balance (in shares) at Sep. 30, 2021	1,285	32,564
Balance at Sep. 30, 2021	$ 1	$ 33	192,520	(320,346)	(4,301)	(132,093)
Balance (in shares) at Dec. 31, 2021	1,275	33,461
Balance at Dec. 31, 2021	$ 1	$ 33	205,305	(321,227)	(4,350)	(120,238)
Issuance of common stock (in shares)	0	341
Issuance of common stock	$ 0	$ 1	3,348	0	0	3,349
Series B conversion to common stock (in shares)	(5)
Series B conversion to common stock	$ 0	$ 0	0	0	0	0
Series B conversion to common stock, Shares Issued (in shares)		1
Stock options exercised (in shares)	0	263
Stock options exercised	$ 0	$ 0	196	0	0	196
Stock-based compensation	$ 0	$ 0	2,040	0	0	2,040
Issuance and exercise of warrants (in shares)	0	113
Issuance and exercise of warrants	$ 0	$ 0	4,550	0	0	4,550
Foreign currency translation gain (loss)	0	0	0	0	(194)	(194)
Net loss	$ 0	$ 0	0	(18,294)	0	(18,294)
Balance (in shares) at Mar. 31, 2022	1,270	34,179
Balance at Mar. 31, 2022	$ 1	$ 34	215,439	(339,521)	(4,544)	(128,591)
Balance (in shares) at Dec. 31, 2021	1,275	33,461
Balance at Dec. 31, 2021	$ 1	$ 33	205,305	(321,227)	(4,350)	(120,238)
Foreign currency translation gain (loss)						(884)
Net loss						(85,348)
Balance (in shares) at Sep. 30, 2022	1,270	35,043
Balance at Sep. 30, 2022	$ 1	$ 35	226,883	(406,575)	(5,234)	(184,890)
Balance (in shares) at Mar. 31, 2022	1,270	34,179
Balance at Mar. 31, 2022	$ 1	$ 34	215,439	(339,521)	(4,544)	(128,591)
Issuance of common stock (in shares)	0	400
Issuance of common stock	$ 0	$ 1	5,123	0	0	5,124
Stock options exercised (in shares)	0	3
Stock options exercised	$ 0	$ 0	4	0	0	4
Stock-based compensation	0	0	1,349	0	0	1,349
Foreign currency translation gain (loss)	0	0	0	0	(390)	(390)
Net loss	$ 0	$ 0	0	(209)	0	(209)
Balance (in shares) at Jun. 30, 2022	1,270	34,582
Balance at Jun. 30, 2022	$ 1	$ 35	221,915	(339,730)	(4,934)	(122,713)
Issuance of common stock (in shares)	0	319
Issuance of common stock	$ 0	$ 0	2,872	0	0	2,872
Stock options exercised (in shares)	0	29
Stock options exercised	$ 0	$ 0	5	0	0	5
Stock-based compensation	$ 0	$ 0	1,545	0	0	1,545
Issuance and exercise of warrants (in shares)	0	113
Issuance and exercise of warrants	$ 0	$ 0	546	0	0	546
Foreign currency translation gain (loss)	0	0	0	0	(300)	(300)
Net loss	$ 0	$ 0	0	(66,845)	0	(66,845)
Balance (in shares) at Sep. 30, 2022	1,270	35,043
Balance at Sep. 30, 2022	$ 1	$ 35	$ 226,883	$ (406,575)	$ (5,234)	$ (184,890)

Note 1 - Nature of Activities a

Note 1 - Nature of Activities and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	1. Nature of Activities and Summary of Significant Accounting Policies Nature of Activities. Founded in 2006 three not We own and operate a 65 million gallon per year ethanol production facility located in Keyes, California (the “Keyes Plant”). In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains (“WDG”), Distillers Corn Oil (“DCO”), and Condensed Distillers Solubles (“CDS”), all of which are sold as animal feed to local dairies and feedlots. In the third 2022, TM first Aemetis Biogas, LLC (“ABGL”) was formed to construct bio-methane anaerobic digesters at local dairies near the Keyes Plant, many of whom also purchase WDG produced at the Keyes Plant. The digesters are connected via an underground private pipeline owned by ABGL to a gas cleanup and compression unit being built at the Keyes Plant to produce dairy renewable natural gas (“RNG”). Upon receiving the bio-methane from the dairies, impurities are removed, and the bio-methane is converted to negative carbon intensity RNG that will either be injected into the statewide PG&E gas utility pipeline, supplied as compressed RNG that will service local trucking fleets, or used as renewable process energy at the Keyes Plant. Our Carbon Zero biofuels production plants are designed to produce biofuels, including sustainable aviation fuel (“SAF”) and diesel fuel utilizing renewable hydrogen and non-edible renewable oils sourced from existing Aemetis biofuels plants and other sources. The first 90 D3 D3 D6 D3 Aemetis Carbon Capture, Inc. was formed to build Carbon Capture and Sequestration ("CCS") projects to generate LCFS and IRS 45Q two million two July 2022, 24 one million We also own and operate a production facility on the East Coast of India (the “Kakinada Plant”) with a nameplate capacity of 150 50 Basis of Presentation and Consolidation. not All intercompany balances and transactions have been eliminated in consolidation. The accompanying consolidated condensed balance sheet as of September 30, 2022 three nine September 30, 2022 2021 nine September 30, 2022 2021 three nine September 30, 2022 2021 December 31, 2021 2021 2021 10 December 31, 2021 In the opinion of Company’s management, the unaudited interim consolidated condensed financial statements as of and for the three nine September 30, 2022 2021 December 31, 2021 three nine September 30, 2022 not Use of Estimates Revenue Recognition 606 California Ethanol: May 13, 2020, May 13, 2020, May 13, 2020 October, 2021, one September 30, 2021. October 1, 2021, one one The below table shows our sales in our California Ethanol segment by product category: For the three months ended September 30, For the nine months ended September 30, 2022 2021 2022 2021 Ethanol and high-grade alcohol sales $ 44,673 $ 39,131 $ 130,224 $ 111,220 Wet distiller's grains sales 13,003 8,919 39,669 30,584 Other sales 3,231 1,782 8,947 5,086 $ 60,908 $ 49,832 $ 178,840 $ 146,890 We have elected to adopt the practical expedient that allows for ignoring the significant financing component of a contract when estimating the transaction price when the transfer of promised goods to the customer and customer payment for such goods are expected to be within one one We also assessed principal versus agent criteria as we buy our feedstock from our customers and process and sell finished goods to those customers in certain contractual agreements. For our California Ethanol segment, we buy corn as feedstock for the production of ethanol, from our working capital partner J.D. Heiskell. Prior to May 13, 2020, May 13, 2020, one second 2021, October 1, 2021 not We consider the purchase of corn as a cost of goods sold and the sale of WDG and, corn oil, upon trucks leaving the Keyes Plant, as revenue on the basis that (i) we control and bear the risk of gain or loss on the processing of corn which is purchased at market prices into ethanol and (ii) we have legal title to the goods during the processing time. The pricing for both WDG and corn oil is set independently. Revenues from WDG and corn oil are billed net of the related transportation and marketing charges. The transportation component is accounted for in cost of goods sold and the marketing component is accounted for in sales, general and administrative expense. Transportation and marketing charges are known within days of the transaction and are recorded at the actual amounts. We have elected an accounting policy under which these charges have been treated as fulfillment activities provided after control has transferred. As a result, these charges are recognized in cost of goods sold and selling, general and administrative expenses, respectively, when revenue is recognized. Revenues are recorded at the gross invoiced amount. Hence, we are the principal in California Ethanol segment where our customer and vendor may Dairy Renewable Natural Gas: three nine September 30, 2022 2021 10 India Biodiesel: not one The below table shows our sales in our India Biodiesel Segment by product category: For the three months ended September 30, For the nine months ended September 30, 2022 2022 2021 2022 2021 Biodiesel sales $ 10,828 $ - $ 10,828 $ 465 Other sales 95 63 113 231 $ 10,923 $ 63 $ 10,941 $ 696 In India, we also assessed principal versus agent criteria as we buy our feedstock from our customers and process and sell finished goods to those same customers in certain contractual agreements. In those cases, we receive the legal title to feedstock from our customers once it is on our premises. We control the processing and production of biodiesel based on contract terms and specifications. The pricing for both feedstock and biodiesel is set independently. We hold the title and risk to biodiesel according to agreements when we enter into in these situations. Hence, we are the principal in India sales scenarios where our customer and vendor may Cost of Goods Sold S hipping and Handling Costs. Research and Development. Cash and Cash Equivalents. three may not Accounts Receivable. third 30 may 30 The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivables are charged against the allowance for doubtful accounts once un-collectability has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, additional allowances may December 31, 2021 second 2022. Inventories first first Variable Interest Entities. 1 2 not Property, Plant and Equipment not The Company evaluates the recoverability of long-lived assets with finite lives in accordance with ASC Subtopic 360 10 35 Property Plant and Equipment Subsequent Measurements, may not may not not three nine September 30, 2022 2021 California Energy Commission Low-Carbon Fuel Production Program September 30, 2022 California Department of Food and Agriculture Dairy Digester Research and Development Grant 2019, two second 2021. In October 2020, six 2020 September 30, 2022 . California Energy Commission Low Carbon Advanced Ethanol Grant Program. May 2019, not September 30, 2022 December 31, 2021. U.S. Department of Food and Agriculture Forest Service Grant. September 30, 2022 California Energy Commission Grant for Solar Microgrid, DSC and Battery Backup System. 1.56 1.25MW/2.5MWh September 30, 2022 California Department of Forestry and Fire Protection Grant. AAPK has been awarded $2 million in matching grants from the CAL FIRE Business and Workforce Development Grant Program (“CAL Fire”) in May 2022. 2 100% no September 30, 2022 California Department of Forestry and Fire Protection Grant. AAPK has been awarded $500 thousand in grants from CAL Fire in May 2022. no September 30, 2022 U.S Forest Service Community Wood Grant. Aemetis Advanced Products Riverbank (“AAPR”) has been awarded $642 thousand in matching grants from the U.S Forest Service Wood Innovations Program (“USFS”) in May 2022. 3 no September 30, 2022 USDA s Biofuel Producer Program Grant. second 2022, 19 California Energy Commission Grant for Mechanical Vapor Recompression System. no September 30, 2022 Basic and Diluted Net Loss per Share. three nine September 30, 2022 2021 The following table shows the number of potentially dilutive shares excluded from the diluted net loss per share calculation as of September 30, 2022 2021 As of September 30, 2022 September 30, 2021 Series B preferred (post split basis) 127 129 Common stock options and warrants 5,064 3,929 Debt with conversion feature at $ 30 1,256 1,280 Total number of potentially dilutive shares excluded from the diluted net (loss) per share calculation 6,447 5,338 Comprehensive Income (Loss). 220 Comprehensive Income (Loss) not Foreign Currency Translation/Transactions. Segments. three The “California Ethanol” reportable segment includes the Company’s 65 The “Dairy Renewable Natural Gas” reportable segment include, the dairy digesters, pipeline and gas condition hub for the production of biogas from dairies near Keyes, California. The “India Biodiesel” reportable segment includes the Company’s 50 The Company has additional operating segments that were determined not 1 Fair Value of Financial Instruments. not 3 Share-Based Compensation. 718 Stock Compensation Commitments and Contingencies. 450 Contingencies 450 one Convertible Instruments Debt Modification Accounting 470 50 Debt Modification and Extinguishments 10 10 For a complete summary of the Company’s significant accounting policies, please refer to the Company’s audited financial statements and notes thereto for the years ended December 31, 2021 2020 10 March 10, 2022.

Note 2 - Inventories

Note 2 - Inventories	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	2. Inventories Inventories consist of the following: As of September 30, 2022 December 31, 2021 Raw materials $ 1,526 $ 727 Work-in-progress 2,911 2,083 Finished goods 5,994 2,316 Total inventories $ 10,431 $ 5,126 As of September 30, 2022 December 31, 2021, none

Note 3 - Property, Plant and Eq

Note 3 - Property, Plant and Equipment	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	3. Property, Plant and Equipment Property, plant and equipment consist of the following: As of September 30, 2022 December 31, 2021 Land $ 7,352 $ 4,082 Plant and buildings 99,220 97,110 Furniture and fixtures 1,697 1,334 Machinery and equipment 15,613 5,294 Tenant improvements 56 - Construction in progress 76,225 55,859 Property held for development 15,437 15,437 Finance lease right of use assets 3,045 2,317 Total gross property, plant & equipment 218,645 181,433 Less accumulated depreciation (49,160 ) (46,332 ) Total net property, plant & equipment $ 169,485 $ 135,101 For the three September 30, 2022 2021 nine September 30, 2022 2021 Construction in progress includes costs for the biogas construction projects (dairy digesters and pipeline), Riverbank projects (sustainable aviation fuel and renewable diesel plant as well as carbon capture characterization well), and energy efficiency projects at the Keyes Plant. Depreciation on the components of property, plant and equipment is calculated using the straight-line method to allocate their depreciable amounts over their estimated useful lives as follows: Years Plant and buildings 20 - 30 Machinery and equipment 5 - 15 Furniture and fixtures 3 - 5 For the three September 30, 2022 2021 nine September 30, 2022 2021

Note 4 - Debt

Note 4 - Debt	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	4. Debt Debt consists of the following: September 30, 2022 December 31, 2021 Third Eye Capital term notes $ 7,113 $ 7,095 Third Eye Capital revolving credit facility 57,950 75,980 Third Eye Capital revenue participation term notes 11,939 11,915 Third Eye Capital acquisition term notes 26,521 26,461 Third Eye Capital Fuels Revolving Line 25,080 - Third Eye Capital Carbon Revolving Line 22,484 - Cilion shareholder seller notes payable 6,769 6,619 Subordinated notes 15,226 14,304 EB-5 promissory notes 41,204 40,692 Term loans on capital expenditures 5,983 5,701 Working capital loans 2,713 - Total debt 222,982 188,767 Less current portion of debt 29,020 22,778 Total long term debt $ 193,962 $ 165,989 Third Eye Capital Note Purchase Agreement On July 6, 2012, On February 27, 2019, “February 2019 April 30, 2019. February 2019 April 30, 2019, February 2019 third 2019, February 2019 first 2020, February 2019 February 2019 first 2021. On March 14, 2021, No. 19 No. 19” December 31, 2021, ( March 31, 2021. No. 19 April 1, 2022 may may 60 No. 19 470 50 On August 9, 2021, No. 20 No. 20” may April 1, 2023 may March 31, 2022, June 30, 2022, September 30, 2022 December 31, 2022; June 30, 2021 No.20 470 50 first 2022, April 1, 2023. On November 5, 2021, No. 21 No. 21” August 31, 2021 No.21 470 50 On March 8, 2022, No. 22 No. 22” December 31, 2021, ( December 31, 2021. On May 11, 2022, No. 23 No. 23” March 31, 2022, ( March 31, 2023 March 31, 2022 On August 8th, 2022, No. 24 No. 24" may April 1, 2024 may No. 24 Amendments No. 19 No. 24 September 30, 2022 March 31, 2023. 470 10 45 not 12 12 5 12 On March 6, 2020, one March 14, 2021, March 14, 2021 April 1, 2023. may third April 1, 2023. may April 1, 2023. one may August 9, 2021, Terms of Third Eye Capital Notes A. Term Notes. September 30, 2022 April 1, 2023*. B. Revolving Credit Facility . September 30, 2022 April 1, 2023*. September 30, 2022 C. Revenue Participation Term Notes . April 1, 2023*. September 30, 2022 D. Acquisition Term Notes . September 30, 2022 April 1, 2023*. September 30, 2022 E. Reserve Liquidity Notes . April 1, 2023. September 30, 2022 * The note maturity date can be extended by the Company to April 2024. The Third Eye Capital Notes contain various covenants, including but not not twelve The Third Eye Capital Notes are secured by first GAFI Term Loan and Revolving Loan. July 10, 2017, 6. not July 10, 2021 first 2021 Third Eye Capital Revolving Credit Facility for Fuels and Carbon Lines. March 2, 2022, two March 1, 2025 ten March 1, 2026 eight five March 2, 2022; ten March 2, 2022. As of September 30, 2022 September 30, 2022 Cilion shareholder seller notes payable July 6, 2012, $5.0 September 30, 2022 Subordinated Notes January 6 January 9, 2012, two six two may On January 1, 2022, two June 30, 2022; ( two On July 1, 2022, two December 31, 2022; ( two The Company evaluated the January 1, 2022 July 1 2022 470 50 At September 30, 2022 December 31, 2021 EB- 5 5 March 4, 2011 ( January 19, 2012 July 24, 2012) 5 72 5 2 3%. four 5 one two one no February 27, 2019, 5 six six 5 12 5 19 not 829 5 three The Company has sold an aggregate principal amount of $36.0 million of EB- 5 5 2012 September 30, 2022 September 30, 2022 December 31, 2021 5 5 On October 16, 2016, 5 5 $50.0 5 5 November 21, 2019, 5 100 5 May 1, 2020 No. 3 5 60. 5 52 5 may 5 five 5 The Company has sold an aggregate principal amount of $4.0 million of EB- 5 5 2016 September 30, 2022 $4.0 September 30, 2022 5 5 Secunderabad Oils Operating Agreement. November 2008, 2008 first 2008 July 15, 2017, 95 second September 30, 2022 December 31, 2021, Working capital loans. July 26, 2022, not August 1, 2022, not one September 30, 2022, Construction Loan Agreement. October 4, 2022, not 1 March 4, 2023, 80% 2023, September 30, 2022, no Financing Agreement for capital expenditures. TM September 30, 2022 Scheduled debt repayments for the Company’s loan obligations by year are as follows: Twelve Months ended September 30, Debt Repayments 2023 $ 29,020 2024 136,757 2025 32,240 2026 28,612 2027 985 There after 1,136 Total debt 228,750 Debt issuance costs (5,768 ) Total debt, net of debt issuance costs $ 222,982

Note 5 - Commitments and Contin

Note 5 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	5. Leases We have identified assets as the corporate office, warehouse, monitoring equipment and laboratory facilities over which we have control and obtain economic benefits fully. We classified these identified assets as operating leases after assessing the terms under classification guidance. We have entered into several leases for trailers and carbon units with purchase option at the end of the term. We have concluded that it is reasonably certain that we would exercise the purchase option at the end of the term, hence the leases were classified as finance leases. All of our leases have remaining term of less than a year to 15 years. We made an accounting policy election to keep leases with an initial term of 12 When discount rates implicit in leases cannot be readily determined, the Company uses the applicable incremental borrowing rate at lease commencement to perform lease classification tests on lease components and measure lease liabilities and right-of-use (“ROU”) assets. The incremental borrowing rate used by the Company was based on weighted average baseline rates commensurate with the Company’s secured borrowing rate over a similar term. At each reporting period, when there is a new lease initiated, the rates established for that quarter will be used. On December 14, 2021, 5300 1 April 1, 2022. 842 The components of lease expense and sublease income were as follows: Three months ended September 30, Nine months ended September 30, 2022 2021 2022 2021 Operating lease cost Operating lease expense $ 159 $ 204 $ 506 $ 612 Short term lease expense 44 28 146 138 Variable lease expense 23 30 68 84 Total operating lease cost $ 226 $ 262 $ 720 $ 834 Finance lease cost Amortization of right-of-use assets $ 26 $ 58 $ 115 $ 168 Interest on lease liabilities 98 20 217 61 Total finance lease cost $ 124 $ 78 $ 332 $ 229 Cash paid for amounts included in the measurement of lease liabilities: Three months ended September 30, Nine months ended September 30, 2022 2021 2022 2021 Operating cash flows used in operating leases $ 184 $ 179 $ 522 $ 519 Operating cash flows used in finance leases 98 20 216 61 Financing cash flows used in finance leases $ 132 $ 126 $ 314 $ 373 Supplemental non-cash flow information related to ROU asset and lease liabilities was as follows for the three nine September 30, 2022 2021 Three months ended September 30, Nine months ended September 30, 2022 2021 2022 2021 Operating leases Accretion of the lease liability $ 83 $ 93 $ 262 $ 288 Amortization of right-of-use assets 76 111 244 324 Weighted Average Remaining Lease Term Operating leases (in years) 5.6 Finance leases (in years) 14.2 Weighted Average Discount Rate Operating leases 14.0 % Finance leases 13.2 % Supplemental balance sheet information related to leases was as follows: September 30, 2022 December 31, 2021 Operating leases Operating lease right-of-use assets $ 2,227 $ 2,462 Current portion of operating lease liability 267 260 Long term operating lease liability 2,120 2,318 Total operating lease liabilities 2,387 2,578 Finance leases Property and equipment, at cost $ 3,045 $ 2,317 Accumulated depreciation (79 ) (376 ) Property and equipment, net 2,966 1,941 Other current liability 118 550 Other long term liabilities 2,854 720 Total finance lease liabilities 2,972 1,270 Maturities of operating lease liabilities were as follows: Twelve months ended September 30, Operating leases Finance leases 2023 $ 572 $ 479 2024 586 204 2025 603 176 2026 622 145 2027 641 145 There after 442 11,000 Total lease payments 3,466 12,149 Less imputed interest (1,079 ) (9,177 ) Total lease liability $ 2,387 $ 2,972 The Company acts as sublessor in certain leasing arrangements, primarily related to land and buildings. Fixed sublease payments received are recognized on a straight-line basis over the sublease term. Sublease income and head lease expense for these transactions are recognized on a gross basis on the consolidated financial statements. This was recorded in the other operating income section of the Consolidated Statements of Operations and Comprehensive Loss. The components of lease income for the three nine September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Lease income $ 804 $ - Future lease commitments to be received by the Company as of September 30, 2022 Twelve months ended September 30, 2023 $ 858 2024 643 2025 521 2026 474 2027 474 There after 1,184 Total future lease commitments $ 4,154 Property taxes On March 3, 2022, Legal Proceedings On August 31, 2016, July 24, 2019, May 6, 2022 second 2022.

Note 6 - Aemetis Biogas LLC, Se

Note 6 - Aemetis Biogas LLC, Series A Preferred Financing and Variable Interest Entity	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	6. Series A Preferred Financing and Variable Interest Entity On December 20, 2018, X ABGL is authorized to issue 11,000,000 common units, and up to 6,000,000 convertible, redeemable, secured, preferred membership units (the “Series A Preferred Units”). ABGL issued 6,000,000 common units to the Company at $5.00 per common unit for a total of $30,000,000 in funding. Additionally, 5,000,000 common units of ABGL are held in reserve as potential conversion units issuable to the Purchaser upon certain triggering events discussed below. The Preferred Unit Agreement includes (i) preference payments of $0.50 per unit on the outstanding Series A Preferred Units commencing on the second ten one one one three sixth not Triggering events occur upon ABGL’s failure to redeem units, comply with covenants, any other defaults or cross defaults, or to perform representations or warranties. Upon a triggering event: (i) the obligation of the Purchaser to purchase additional Series A Preferred Units is terminated, (ii) cash flow payments for redemption payments increases from 75% to 100% of free cash flows, and (iii) total number of common units into which preferred units may one one September 30, 2022 not may 100% 75% On August 8th, 2022, X December 20, 2018. December 31, 2022 ( September 30, 2022 January 1, 2023. 470 50 From inception of the agreement to date, ABGL issued 3,200,000 Series A Preferred Units on first second August 8, 2022 three December 31, 2022 September 30, 2022 December 31, 2021 In the three March 31, 2021, second The Company recorded Series A Preferred Unit liabilities, net of unit issuance costs and inclusive of accretive preference pursuant to this agreement, and accrued preference payments, classified as current portion of Series A Preferred Units, of $109.4 million and $3.2 million, and long-term liabilities of $0 and $45.0 million as of September 30, 2022 December 31, 2021 Variable interest entity assessment After consideration of ABGL’s operations and the above agreement, we concluded that ABGL did not September 30, 2022 not

Note 7 - Stock-based Compensati

Note 7 - Stock-based Compensation	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Shareholders' Equity and Share-Based Payments [Text Block]	7. 2019 On April 29, 2019, 2019 “2019 may 2019 2019 2019 2007 With the approval of the 2019 2006 2007 2019 2019 During the year ended December 31, 2021 2019 During the nine September 2022, 2019 Common Stock Reserved for Issuance The following is a summary of awards granted under the Stock Plans: Shares Available for Grant Number of Shares Outstanding Weighted-Average Exercise Price Balance as of December 31, 2021 142 3,763 $ 2.29 Authorized 1,338 - - Options Granted (1,307 ) 1,307 10.97 RSAs Granted (89 ) - - Exercised - (294 ) 0.93 Forfeited/expired 67 (67 ) 11.44 Balance as of September 30, 2022 151 4,709 $ 4.65 As of September 30, 2022 Stock-based compensation for employees Stock-based compensation is accounted for in accordance with the provisions of ASC 718 Compensation-Stock Compensation Valuation and Expense Information All issuances of stock options or other issuances of equity instruments to employees as the consideration for services received by us are accounted for based on the fair value of the equity instrument issued. The fair value of options granted to employees is estimated on the grant date using the Black-Scholes option valuation model. This valuation model for stock based compensation expense requires us to make assumptions and judgments about the variables used in the calculation, including the fair value of our common stock, the expected term (the period of time that the options granted are expected to be outstanding), the volatility of our common stock, a risk-free interest rate, and expected dividends. Under ASU 2016 09 Improvements to Employee Share-Based Payments Accounting No. 107, four not zero During the three September 30, 2022 2021 For the nine months ended September 30, 2022 Description 2022 2021 Dividend-yield - % - % Risk-free interest rate 2.03 % 0.83 % Expected volatility 117.21 % 100.47 % Expected life (years) 7.00 6.59 Market value per share on grant date $ 10.97 $ 5.30 Fair value per option on grant date $ 9.71 $ 4.68 As of September 30, 2022

Note 8 - Outstanding Warrants

Note 8 - Outstanding Warrants	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Outstanding Warrants [Text Block]	8. The weighted average fair value calculations for warrants granted are based on the following weighted average assumptions: For the nine months ended September 30, 2022 Description 2022 2021 Dividend-yield - % - % Risk-free interest rate 1.75 % 0.19 % Expected volatility 151.41 % 139.35 % Expected life (years) 3.52 2.00 Exercise price per warrant $ 10.47 $ 0.01 Market value per share on grant date $ 11.29 $ 6.83 Fair value per warrant on grant date $ 9.68 $ 6.82 A summary of historical warrant activity follows: Warrants Outstanding & Exercisable Weighted - Average Exercise Price Average Remaining Term in Years Outstanding December 31, 2020 95 $ 2.59 4.95 Granted 292 0.01 Exercised (332 ) 0.32 Outstanding December 31, 2021 55 $ 2.59 3.95 Granted 527 10.46 Exercised (227 ) 0.01 Outstanding September 30, 2022 355 $ 15.92 7.74 All of the above outstanding warrants are vested and exercisable as of September 30, 2022 September 30, 2022 2021 no

Note 9 - Agreements

Note 9 - Agreements	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Agreements [Text Block]	9. Working Capital Arrangement. December 31, 2022 one May 13, 2020, No.1 As of September 30, 2022 December 31, 2021 The J.D. Heiskell sales and purchases activity associated with the J.D. Heiskell Purchase Agreement and J.D. Heiskell Procurement Agreement during the three nine September 30, 2022 2021 As of and for the three months ended September 30, As of and for the nine months ended September 30, 2022 2021 2022 2021 Wet distiller's grains sales $ 13,003 $ 8,919 $ 39,669 $ 30,584 Corn oil sales 2,917 1,515 8,067 4,252 Corn purchases 53,063 39,058 151,425 119,217 Accounts receivable 106 88 106 88 Accounts payable 540 307 540 307 Ethanol and Wet Distillers Grains Marketing Arrangement. December 31, 2022, one September 30, 2021. October 1, 2021, October 31, 2023, one Accounts receivable associated with our marketing partners was $0.2 million and $1.2 million as of September 30, 2022 December 31, 2021 For the three September 30, 2022 2021 nine September 30, 2022 2021 Supply Trade Agreement. July 1, 2022, ten one one September 30, 2022 December 31, 2021, As of September 30, 2022 2021

Note 10 - Segment Information

Note 10 - Segment Information	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	10. Segment Information Aemetis recognizes three reportable segments: “California Ethanol”, “Dairy Renewable Natural Gas”, and “India Biodiesel.” The “California Ethanol” reportable segment includes the Company’s 65 million gallon per year Keyes Plant, and the adjacent land leased for the production of CO₂. The “Dairy Renewable Natural Gas” reportable segment includes, the dairy digesters, pipeline and gas condition hub for the production of biogas from dairies near Keyes, California. The “India Biodiesel” reportable segment includes the Company’s 50 million gallon per year nameplate capacity biodiesel manufacturing Kakinada Plant, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Company’s biodiesel is marketed and sold primarily to customers in India through brokers and by the Company directly. The Company has additional operating segments that were determined not 1 Summarized financial information by reportable segment for the three September 30, 2022 2021 For the three months ended September 30, 2022 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 60,908 $ - $ 10,923 $ - $ 71,831 Intersegment revenues - 308 - - 308 Gross profit (loss) (3,763 ) (179 ) 2,841 (3 ) (1,104 ) Interest expense 4,744 1 69 2,275 7,089 Accretion and other expenses of Series A preferred units - 2,774 - - 2,774 Capital expenditures 210 3,626 - 2,577 6,413 Depreciation 1,023 156 161 38 1,378 Total Assets 65,567 65,076 22,415 45,817 198,875 For the three months ended September 30, 2021 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 49,832 $ - $ 63 $ - $ 49,895 Intersegment revenues - 355 - - 355 Gross profit (loss) (4,413 ) (397 ) 47 (22 ) (4,785 ) Interest expense 5,563 3 - (18 ) 5,548 Accretion and other expenses of Series A preferred units - 2,185 - - 2,185 Capital expenditures 749 3,111 21 1,955 5,836 Depreciation 1,020 145 155 22 1,342 Total Assets 69,454 34,769 11,259 31,497 146,979 A reconciliation of reportable segment revenues to total consolidated revenue for the three September 30, 2022 2021 2022 2021 Total revenues for reportable segments $ 72,139 $ 50,250 Elimination of intersegment revenues (308 ) (355 ) Total consolidated revenues $ 71,831 $ 49,895 Summarized financial information by reportable segment for the nine September 30, 2022 2021 For the nine months ended September 30, 2022 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 178,840 $ - $ 10,941 $ - $ 189,781 Intersegment revenues - 940 - - 940 Gross profit (loss) (6,795 ) (454 ) 2,859 (13 ) (4,403 ) Interest expense 15,258 12 69 4,679 20,018 Accretion and other expenses of Series A preferred units - 5,920 - - 5,920 Capital expenditures 7,379 15,771 136 5,645 28,931 Depreciation 3,011 456 493 79 4,039 Total Assets 65,567 65,076 22,415 45,817 198,875 For the nine months ended September 30, 2021 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 146,890 $ - $ 696 $ - $ 147,586 Intersegment revenues - 1,090 - - 1,090 Gross profit (loss) (4,172 ) (482 ) (23 ) (70 ) (4,747 ) Interest expense 16,248 9 - 1,690 17,947 Accretion and other expenses of Series A preferred units - 7,928 - - 7,928 Capital expenditures 1,524 10,006 139 7,102 18,771 Depreciation 3,122 429 513 42 4,106 Total Assets 69,454 34,769 11,259 31,497 146,979 A reconciliation of reportable segment revenues to total consolidated revenues for the nine September 30, 2022 2021 2022 2021 Total revenues for reportable segments $ 190,721 $ 148,676 Elimination of intersegment revenues (940 ) (1,090 ) Total consolidated revenues $ 189,781 $ 147,586 California Ethanol: two three September 30, 2022 two three September 30, 2021 two nine September 30, 2022 two nine September 30, 2021 Dairy Renewable Natural Gas: three nine September 30, 2022 2021 India Biodiesel: Three biodiesel customers sales customers accounted for 52%, 23%, and 22% of the Company’s consolidated India segment revenues for the three nine September 30, 2022. three September 30, 2021. one nine September 30, 2021.

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	11. Related Party Transactions The Company owes Eric McAfee, the Company’s Chairman and CEO, and McAfee Capital LLC (“McAfee Capital”), owned by Eric McAfee, $0.4 million in connection with employment agreements and expense reimbursements previously accrued as salaries expense and accrued liabilities. The Company previously prepaid $0.2 million to Redwood Capital, a company controlled by Eric McAfee, for the Company’s use of flight time on a corporate jet. As of September 30, 2022 On November 4, 2021, none September 30, 2022 December 31, 2021 January 12, 2022, one The Company owes various members of the Board amounts totaling $0.3 and $0.2 million as of September 30, 2022 December 31, 2021 three September 30, 2022 2021 nine September 30, 2022 2021

Note 12 - Subsequent Events

Note 12 - Subsequent Events	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	12. Subsequent Events Construction Loan Agreement On October 4, 2022, not 1 March 4, 2023, 80% 2023, September 30, 2022, no

Note 13 - Managements Plan

Note 13 - Managements Plan	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	13. Management s Plan The accompanying financial statements have been prepared contemplating the realization of assets and satisfaction of liabilities in the normal course of business. As a result of negative capital and negative operating results, and collateralization of substantially all of the company assets, the Company has been reliant on its senior secured lender to provide additional funding and has been required to remit substantially all excess cash from operations to the senior secured lender. In order to meet its obligations during the next twelve For the Keyes Plant, we plan to operate the plant and continue to improve financial performance by adopting new technologies or process changes that allow for energy efficiency, cost reduction or revenue enhancements, execute upon awarded grants that improve energy and operational efficiencies resulting in lower cost, lower carbon demands and overall margin improvement. For Aemetis Biogas we plan to operate the biogas digesters to capture and monetize biogas as well as continue to build new dairy digesters and extend the existing pipeline in order to capture the higher carbon credits available in California. Funding for continued construction is based upon obtaining government guaranteed loans and executing on existing and new state grant programs. For the Riverbank project, we plan to raise the funds necessary to construct and operate the Carbon Zero 1 For the Kakinada Plant, we plan to develop sales channels for domestic products as the costs of feedstock normalize against the price of diesel, as recently announced governmental incentives take effect to promote the blending of biodiesel, and as feedstocks such as refined animal tallow are used domestically and exported. Additionally, we are in the process of obtaining approval to export refined animal tallow and biodiesel produced using animal tallow into international markets as the use of refined animal tallow received approval from the Pollution Control Board of India for production of biodiesel. In addition to the above we plan to continue to locate funding for existing and new business opportunities through a combination of working with our senior lender, restructuring existing loan agreements, selling bonds in the taxable and tax-exempt markets, selling equity through the ATM and otherwise, selling the current EB- 5

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation and Consolidation. not All intercompany balances and transactions have been eliminated in consolidation. The accompanying consolidated condensed balance sheet as of September 30, 2022 three nine September 30, 2022 2021 nine September 30, 2022 2021 three nine September 30, 2022 2021 December 31, 2021 2021 2021 10 December 31, 2021 In the opinion of Company’s management, the unaudited interim consolidated condensed financial statements as of and for the three nine September 30, 2022 2021 December 31, 2021 three nine September 30, 2022 not
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
Revenue [Policy Text Block]	Revenue Recognition 606 California Ethanol: May 13, 2020, May 13, 2020, May 13, 2020 October, 2021, one September 30, 2021. October 1, 2021, one one The below table shows our sales in our California Ethanol segment by product category: For the three months ended September 30, For the nine months ended September 30, 2022 2021 2022 2021 Ethanol and high-grade alcohol sales $ 44,673 $ 39,131 $ 130,224 $ 111,220 Wet distiller's grains sales 13,003 8,919 39,669 30,584 Other sales 3,231 1,782 8,947 5,086 $ 60,908 $ 49,832 $ 178,840 $ 146,890 We have elected to adopt the practical expedient that allows for ignoring the significant financing component of a contract when estimating the transaction price when the transfer of promised goods to the customer and customer payment for such goods are expected to be within one one We also assessed principal versus agent criteria as we buy our feedstock from our customers and process and sell finished goods to those customers in certain contractual agreements. For our California Ethanol segment, we buy corn as feedstock for the production of ethanol, from our working capital partner J.D. Heiskell. Prior to May 13, 2020, May 13, 2020, one second 2021, October 1, 2021 not We consider the purchase of corn as a cost of goods sold and the sale of WDG and, corn oil, upon trucks leaving the Keyes Plant, as revenue on the basis that (i) we control and bear the risk of gain or loss on the processing of corn which is purchased at market prices into ethanol and (ii) we have legal title to the goods during the processing time. The pricing for both WDG and corn oil is set independently. Revenues from WDG and corn oil are billed net of the related transportation and marketing charges. The transportation component is accounted for in cost of goods sold and the marketing component is accounted for in sales, general and administrative expense. Transportation and marketing charges are known within days of the transaction and are recorded at the actual amounts. We have elected an accounting policy under which these charges have been treated as fulfillment activities provided after control has transferred. As a result, these charges are recognized in cost of goods sold and selling, general and administrative expenses, respectively, when revenue is recognized. Revenues are recorded at the gross invoiced amount. Hence, we are the principal in California Ethanol segment where our customer and vendor may Dairy Renewable Natural Gas: three nine September 30, 2022 2021 10 India Biodiesel: not one The below table shows our sales in our India Biodiesel Segment by product category: For the three months ended September 30, For the nine months ended September 30, 2022 2022 2021 2022 2021 Biodiesel sales $ 10,828 $ - $ 10,828 $ 465 Other sales 95 63 113 231 $ 10,923 $ 63 $ 10,941 $ 696 In India, we also assessed principal versus agent criteria as we buy our feedstock from our customers and process and sell finished goods to those same customers in certain contractual agreements. In those cases, we receive the legal title to feedstock from our customers once it is on our premises. We control the processing and production of biodiesel based on contract terms and specifications. The pricing for both feedstock and biodiesel is set independently. We hold the title and risk to biodiesel according to agreements when we enter into in these situations. Hence, we are the principal in India sales scenarios where our customer and vendor may
Cost of Goods and Service [Policy Text Block]	Cost of Goods Sold
Shipping and Handling Costs [Policy Text Block]	S hipping and Handling Costs.
Receivable [Policy Text Block]	Accounts Receivable. third 30 may 30 The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivables are charged against the allowance for doubtful accounts once un-collectability has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, additional allowances may December 31, 2021 second 2022.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents. three may not
Inventory, Policy [Policy Text Block]	Inventories first first
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	Variable Interest Entities. 1 2 not
Property, Plant and Equipment, Policy [Policy Text Block]	Property, Plant and Equipment not The Company evaluates the recoverability of long-lived assets with finite lives in accordance with ASC Subtopic 360 10 35 Property Plant and Equipment Subsequent Measurements, may not may not not three nine September 30, 2022 2021
California Energy Commission Low Carbon Fuel Production Program [Policy Text Block]	California Energy Commission Low-Carbon Fuel Production Program September 30, 2022
California Department of Food and Agriculture Dairy Digester Research and Development Grant [Policy Text Block]	California Department of Food and Agriculture Dairy Digester Research and Development Grant 2019, two second 2021. In October 2020, six 2020 September 30, 2022
California Energy Commission Low Carbon Advanced Ethanol Grant Program [Policy Text Block]	California Energy Commission Low Carbon Advanced Ethanol Grant Program. May 2019, not September 30, 2022 December 31, 2021.
U.S. Department of Food and Agriculture Forest Service Grant [Policy Text Block]	U.S. Department of Food and Agriculture Forest Service Grant. September 30, 2022
California Energy Commission Grant For Solar Microgrid DSC and Battery Backup System [Policy Text Block]	California Energy Commission Grant for Solar Microgrid, DSC and Battery Backup System. 1.56 1.25MW/2.5MWh September 30, 2022
California Department of Forestry and Fire Protection Grant [Policy Text Block]	California Department of Forestry and Fire Protection Grant. AAPK has been awarded $2 million in matching grants from the CAL FIRE Business and Workforce Development Grant Program (“CAL Fire”) in May 2022. 2 100% no September 30, 2022
California Department of Forestry and Fire Protection Grant 2 [Policy Text Block]	California Department of Forestry and Fire Protection Grant. AAPK has been awarded $500 thousand in grants from CAL Fire in May 2022. no September 30, 2022
United States Forest Service Community Wood Grant [Policy Text Block]	U.S Forest Service Community Wood Grant. Aemetis Advanced Products Riverbank (“AAPR”) has been awarded $642 thousand in matching grants from the U.S Forest Service Wood Innovations Program (“USFS”) in May 2022. 3 no September 30, 2022
United States Department of Biofuel Producer Program Grant [Policy Text Block]	USDA s Biofuel Producer Program Grant. second 2022, 19
California Energy Commission Grant for Mechanical Vapor Recompression System [Policy Text Block]	California Energy Commission Grant for Mechanical Vapor Recompression System. no September 30, 2022
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Net Loss per Share. three nine September 30, 2022 2021 The following table shows the number of potentially dilutive shares excluded from the diluted net loss per share calculation as of September 30, 2022 2021 As of September 30, 2022 September 30, 2021 Series B preferred (post split basis) 127 129 Common stock options and warrants 5,064 3,929 Debt with conversion feature at $ 30 1,256 1,280 Total number of potentially dilutive shares excluded from the diluted net (loss) per share calculation 6,447 5,338
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income (Loss). 220 Comprehensive Income (Loss) not
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation/Transactions.
Segment Reporting, Policy [Policy Text Block]	Segments. three The “California Ethanol” reportable segment includes the Company’s 65 The “Dairy Renewable Natural Gas” reportable segment include, the dairy digesters, pipeline and gas condition hub for the production of biogas from dairies near Keyes, California. The “India Biodiesel” reportable segment includes the Company’s 50 The Company has additional operating segments that were determined not 1
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments. not 3
Share-Based Payment Arrangement [Policy Text Block]	Share-Based Compensation. 718 Stock Compensation
Commitments and Contingencies, Policy [Policy Text Block]	Commitments and Contingencies. 450 Contingencies 450 one
Convertible Instruments [Policy Text Block]	Convertible Instruments
Debt, Policy [Policy Text Block]	Debt Modification Accounting 470 50 Debt Modification and Extinguishments 10 10 For a complete summary of the Company’s significant accounting policies, please refer to the Company’s audited financial statements and notes thereto for the years ended December 31, 2021 2020 10 March 10, 2022.
Research and Development Expense, Policy [Policy Text Block]	Research and Development.

Note 1 - Nature of Activities_2

Note 1 - Nature of Activities and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the three months ended September 30, For the nine months ended September 30, 2022 2021 2022 2021 Ethanol and high-grade alcohol sales $ 44,673 $ 39,131 $ 130,224 $ 111,220 Wet distiller's grains sales 13,003 8,919 39,669 30,584 Other sales 3,231 1,782 8,947 5,086 $ 60,908 $ 49,832 $ 178,840 $ 146,890 For the three months ended September 30, For the nine months ended September 30, 2022 2022 2021 2022 2021 Biodiesel sales $ 10,828 $ - $ 10,828 $ 465 Other sales 95 63 113 231 $ 10,923 $ 63 $ 10,941 $ 696
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	As of September 30, 2022 September 30, 2021 Series B preferred (post split basis) 127 129 Common stock options and warrants 5,064 3,929 Debt with conversion feature at $ 30 1,256 1,280 Total number of potentially dilutive shares excluded from the diluted net (loss) per share calculation 6,447 5,338

Note 2 - Inventories (Tables)

Note 2 - Inventories (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	As of September 30, 2022 December 31, 2021 Raw materials $ 1,526 $ 727 Work-in-progress 2,911 2,083 Finished goods 5,994 2,316 Total inventories $ 10,431 $ 5,126

Note 3 - Property, Plant and _2

Note 3 - Property, Plant and Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	As of September 30, 2022 December 31, 2021 Land $ 7,352 $ 4,082 Plant and buildings 99,220 97,110 Furniture and fixtures 1,697 1,334 Machinery and equipment 15,613 5,294 Tenant improvements 56 - Construction in progress 76,225 55,859 Property held for development 15,437 15,437 Finance lease right of use assets 3,045 2,317 Total gross property, plant & equipment 218,645 181,433 Less accumulated depreciation (49,160 ) (46,332 ) Total net property, plant & equipment $ 169,485 $ 135,101
Depreciation Of Property, Plant, and Equipment [Table Text Block]	Years Plant and buildings 20 - 30 Machinery and equipment 5 - 15 Furniture and fixtures 3 - 5

Note 4 - Debt (Tables)

Note 4 - Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Debt [Table Text Block]	September 30, 2022 December 31, 2021 Third Eye Capital term notes $ 7,113 $ 7,095 Third Eye Capital revolving credit facility 57,950 75,980 Third Eye Capital revenue participation term notes 11,939 11,915 Third Eye Capital acquisition term notes 26,521 26,461 Third Eye Capital Fuels Revolving Line 25,080 - Third Eye Capital Carbon Revolving Line 22,484 - Cilion shareholder seller notes payable 6,769 6,619 Subordinated notes 15,226 14,304 EB-5 promissory notes 41,204 40,692 Term loans on capital expenditures 5,983 5,701 Working capital loans 2,713 - Total debt 222,982 188,767 Less current portion of debt 29,020 22,778 Total long term debt $ 193,962 $ 165,989
Schedule of Maturities of Long-Term Debt [Table Text Block]	Twelve Months ended September 30, Debt Repayments 2023 $ 29,020 2024 136,757 2025 32,240 2026 28,612 2027 985 There after 1,136 Total debt 228,750 Debt issuance costs (5,768 ) Total debt, net of debt issuance costs $ 222,982

Note 5 - Commitments and Cont_2

Note 5 - Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Lease, Cost [Table Text Block]	Three months ended September 30, Nine months ended September 30, 2022 2021 2022 2021 Operating lease cost Operating lease expense $ 159 $ 204 $ 506 $ 612 Short term lease expense 44 28 146 138 Variable lease expense 23 30 68 84 Total operating lease cost $ 226 $ 262 $ 720 $ 834 Finance lease cost Amortization of right-of-use assets $ 26 $ 58 $ 115 $ 168 Interest on lease liabilities 98 20 217 61 Total finance lease cost $ 124 $ 78 $ 332 $ 229 Three months ended September 30, Nine months ended September 30, 2022 2021 2022 2021 Operating cash flows used in operating leases $ 184 $ 179 $ 522 $ 519 Operating cash flows used in finance leases 98 20 216 61 Financing cash flows used in finance leases $ 132 $ 126 $ 314 $ 373
Supplemental Non-cash Flow Information Related to Leases [Table Text Block]	Three months ended September 30, Nine months ended September 30, 2022 2021 2022 2021 Operating leases Accretion of the lease liability $ 83 $ 93 $ 262 $ 288 Amortization of right-of-use assets 76 111 244 324 Weighted Average Remaining Lease Term Operating leases (in years) 5.6 Finance leases (in years) 14.2 Weighted Average Discount Rate Operating leases 14.0 % Finance leases 13.2 %
Supplemental Balance Sheet Information Related to Leases [Table Text Block]	September 30, 2022 December 31, 2021 Operating leases Operating lease right-of-use assets $ 2,227 $ 2,462 Current portion of operating lease liability 267 260 Long term operating lease liability 2,120 2,318 Total operating lease liabilities 2,387 2,578 Finance leases Property and equipment, at cost $ 3,045 $ 2,317 Accumulated depreciation (79 ) (376 ) Property and equipment, net 2,966 1,941 Other current liability 118 550 Other long term liabilities 2,854 720 Total finance lease liabilities 2,972 1,270
Lease Term [Table Text Block]	Twelve months ended September 30, Operating leases Finance leases 2023 $ 572 $ 479 2024 586 204 2025 603 176 2026 622 145 2027 641 145 There after 442 11,000 Total lease payments 3,466 12,149 Less imputed interest (1,079 ) (9,177 ) Total lease liability $ 2,387 $ 2,972
Operating Lease, Lease Income [Table Text Block]	September 30, 2022 September 30, 2021 Lease income $ 804 $ -
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]	Twelve months ended September 30, 2023 $ 858 2024 643 2025 521 2026 474 2027 474 There after 1,184 Total future lease commitments $ 4,154

Note 7 - Stock-based Compensa_2

Note 7 - Stock-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	Shares Available for Grant Number of Shares Outstanding Weighted-Average Exercise Price Balance as of December 31, 2021 142 3,763 $ 2.29 Authorized 1,338 - - Options Granted (1,307 ) 1,307 10.97 RSAs Granted (89 ) - - Exercised - (294 ) 0.93 Forfeited/expired 67 (67 ) 11.44 Balance as of September 30, 2022 151 4,709 $ 4.65
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	For the nine months ended September 30, 2022 Description 2022 2021 Dividend-yield - % - % Risk-free interest rate 2.03 % 0.83 % Expected volatility 117.21 % 100.47 % Expected life (years) 7.00 6.59 Market value per share on grant date $ 10.97 $ 5.30 Fair value per option on grant date $ 9.71 $ 4.68

Note 8 - Outstanding Warrants (

Note 8 - Outstanding Warrants (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Warrants, Valuation Assumptions [Table Text Block]	For the nine months ended September 30, 2022 Description 2022 2021 Dividend-yield - % - % Risk-free interest rate 1.75 % 0.19 % Expected volatility 151.41 % 139.35 % Expected life (years) 3.52 2.00 Exercise price per warrant $ 10.47 $ 0.01 Market value per share on grant date $ 11.29 $ 6.83 Fair value per warrant on grant date $ 9.68 $ 6.82
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Warrants Outstanding & Exercisable Weighted - Average Exercise Price Average Remaining Term in Years Outstanding December 31, 2020 95 $ 2.59 4.95 Granted 292 0.01 Exercised (332 ) 0.32 Outstanding December 31, 2021 55 $ 2.59 3.95 Granted 527 10.46 Exercised (227 ) 0.01 Outstanding September 30, 2022 355 $ 15.92 7.74

Note 9 - Agreements (Tables)

Note 9 - Agreements (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]	As of and for the three months ended September 30, As of and for the nine months ended September 30, 2022 2021 2022 2021 Wet distiller's grains sales $ 13,003 $ 8,919 $ 39,669 $ 30,584 Corn oil sales 2,917 1,515 8,067 4,252 Corn purchases 53,063 39,058 151,425 119,217 Accounts receivable 106 88 106 88 Accounts payable 540 307 540 307

Note 10 - Segment Information (

Note 10 - Segment Information (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	For the three months ended September 30, 2022 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 60,908 $ - $ 10,923 $ - $ 71,831 Intersegment revenues - 308 - - 308 Gross profit (loss) (3,763 ) (179 ) 2,841 (3 ) (1,104 ) Interest expense 4,744 1 69 2,275 7,089 Accretion and other expenses of Series A preferred units - 2,774 - - 2,774 Capital expenditures 210 3,626 - 2,577 6,413 Depreciation 1,023 156 161 38 1,378 Total Assets 65,567 65,076 22,415 45,817 198,875 For the three months ended September 30, 2021 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 49,832 $ - $ 63 $ - $ 49,895 Intersegment revenues - 355 - - 355 Gross profit (loss) (4,413 ) (397 ) 47 (22 ) (4,785 ) Interest expense 5,563 3 - (18 ) 5,548 Accretion and other expenses of Series A preferred units - 2,185 - - 2,185 Capital expenditures 749 3,111 21 1,955 5,836 Depreciation 1,020 145 155 22 1,342 Total Assets 69,454 34,769 11,259 31,497 146,979 For the nine months ended September 30, 2022 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 178,840 $ - $ 10,941 $ - $ 189,781 Intersegment revenues - 940 - - 940 Gross profit (loss) (6,795 ) (454 ) 2,859 (13 ) (4,403 ) Interest expense 15,258 12 69 4,679 20,018 Accretion and other expenses of Series A preferred units - 5,920 - - 5,920 Capital expenditures 7,379 15,771 136 5,645 28,931 Depreciation 3,011 456 493 79 4,039 Total Assets 65,567 65,076 22,415 45,817 198,875 For the nine months ended September 30, 2021 California Ethanol Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 146,890 $ - $ 696 $ - $ 147,586 Intersegment revenues - 1,090 - - 1,090 Gross profit (loss) (4,172 ) (482 ) (23 ) (70 ) (4,747 ) Interest expense 16,248 9 - 1,690 17,947 Accretion and other expenses of Series A preferred units - 7,928 - - 7,928 Capital expenditures 1,524 10,006 139 7,102 18,771 Depreciation 3,122 429 513 42 4,106 Total Assets 69,454 34,769 11,259 31,497 146,979
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]	2022 2021 Total revenues for reportable segments $ 72,139 $ 50,250 Elimination of intersegment revenues (308 ) (355 ) Total consolidated revenues $ 71,831 $ 49,895 2022 2021 Total revenues for reportable segments $ 190,721 $ 148,676 Elimination of intersegment revenues (940 ) (1,090 ) Total consolidated revenues $ 189,781 $ 147,586

Note 1 - Nature of Activities_3

Note 1 - Nature of Activities and Summary of Significant Accounting Policies (Details Textual) $ in Thousands, gal in Millions	1 Months Ended		3 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2022 USD ($)	Oct. 31, 2020 USD ($)	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($) gal	Dec. 31, 2021 USD ($)
Number of Reportable Segments				3
GallonPerYear (Gallon) | gal				65
Accounts Receivable, Allowance for Credit Loss, Ending Balance				$ 0	$ 1,404
Awarded Grants				8,000
Proceeds from Grantors				3,900
Matching Contribution				1,600
U.S. Department of Food And Agriculture Forest Service [Member]
Awarded Grants				245
Proceeds from Grantors				73
LCFPP [Member]
Awarded Grants				4,200
Proceeds from Grantors				3,800
CDFAs[Member]
Awarded Grants		$ 7,800		3,200
Proceeds from Grantors		$ 2,300
CEC [Member]
Awarded Grants				1,700	1,700
Matching Contribution				7,900
Actual Expenses Incurred				5,000
CEC [Member] | Maximum [Member]
Awarded Grants				5,000
CAL FIRE Business and Workforce Development Grant Program [Member]
Awarded Grants	$ 2,000
Matching Contribution	5,800
CAL Fire [Member]
Awarded Grants	500
CDFA [Member]
Awarded Grants	$ 642
Proceeds from Grantors			$ 14,200
Matching Contribution				2,400
AAFK Plan [Member]
Awarded Grants				6,000
Matching Contribution				$ 5,300
Accounts Receivables [Member]
Accounts Receivable, Allowance for Credit Loss, Ending Balance					$ 1,400

Note 1 - Nature of Activities_4

Note 1 - Nature of Activities and Summary of Significant Accounting Policies - Schedule of America By Product Category (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
India Biodiesel [Member]
Sales	$ 10,923	$ 63	$ 10,941	$ 696
California [Member]
Sales	60,908	49,832	178,840	146,890
Ethanol Sales [Member] | California [Member]
Sales	44,673	39,131	130,224	111,220
Biodiesel Sales [Member] | India Biodiesel [Member]
Sales	10,828	0	10,828	465
Wet Distiller's Grains Sales [Member] | California [Member]
Sales	13,003	8,919	39,669	30,584
Other Sales [Member] | India Biodiesel [Member]
Sales	95	63	113	231
Other Sales [Member] | California [Member]
Sales	$ 3,231	$ 1,782	$ 8,947	$ 5,086

Note 1 - Nature of Activities_5

Note 1 - Nature of Activities and Summary of Significant Accounting Policies - Schedule of Dilutive Securities (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	6,447	5,338
Series B Convertible Preferred Stock [Member]
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	127	129
Common Stock Options and Warrants [Member]
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	5,064	3,929
Debt with Conversion Feature [Member]
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	1,256	1,280

Note 1 - Nature of Activities_6

Note 1 - Nature of Activities and Summary of Significant Accounting Policies - Schedule of Dilutive Securities (Details) (Parentheticals) - $ / shares	Sep. 30, 2022	Sep. 30, 2021
Debt with Conversion Feature [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 30	$ 30

Note 2 - Inventories (Details T

Note 2 - Inventories (Details Textual) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Inventory Write-down	$ 667	$ 0

Note 2 - Inventories - Schedule

Note 2 - Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Raw materials	$ 1,526	$ 727
Work-in-progress	2,911	2,083
Finished goods	5,994	2,316
Total inventories	$ 10,431	$ 5,126

Note 3 - Property, Plant and _3

Note 3 - Property, Plant and Equipment (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Capitalized Interest Costs, Including Allowance for Funds Used During Construction, Total	$ 3.1	$ 1.4	$ 7.7	$ 2.9
Depreciation, Depletion and Amortization, Total	$ 1.4	$ 1.3	$ 4	$ 4.1

Note 3 - Property, Plant and _4

Note 3 - Property, Plant and Equipment - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Land	$ 7,352	$ 4,082
Plant and buildings	99,220	97,110
Furniture and fixtures	1,697	1,334
Machinery and equipment	15,613	5,294
Tenant improvements	56	0
Construction in progress	76,225	55,859
Property held for development	15,437	15,437
Finance lease right of use assets	3,045	2,317
Total gross property, plant & equipment	218,645	181,433
Less accumulated depreciation	(49,160)	(46,332)
Total net property, plant & equipment	$ 169,485	$ 135,101

Note 3 - Property, Plant and _5

Note 3 - Property, Plant and Equipment - Depreciation of property, Plant, and Equipment (Details)	9 Months Ended
	Sep. 30, 2022
Minimum [Member] | Machinery and Equipment [Member]
Plant and buildings (Year)	5 years
Minimum [Member] | Furniture and Fixtures [Member]
Plant and buildings (Year)	3 years
Minimum [Member] | Property, Plant and Equipment [Member]
Plant and buildings (Year)	20 years
Maximum [Member] | Machinery and Equipment [Member]
Plant and buildings (Year)	15 years
Maximum [Member] | Furniture and Fixtures [Member]
Plant and buildings (Year)	5 years
Maximum [Member] | Property, Plant and Equipment [Member]
Plant and buildings (Year)	30 years

Note 4 - Debt (Details Textual)

Note 4 - Debt (Details Textual) - USD ($)

3 Months Ended

9 Months Ended

Jul. 01, 2022

Mar. 02, 2022

Jan. 01, 2022

Aug. 09, 2021

Feb. 27, 2019

Jul. 10, 2017

Jul. 06, 2012

Mar. 04, 2011

Mar. 31, 2020

Sep. 30, 2019

Sep. 30, 2022

Oct. 04, 2022

Aug. 08, 2022

Aug. 01, 2022

Jul. 26, 2022

May 11, 2022

Mar. 08, 2022

Dec. 31, 2021

Nov. 05, 2021

Mar. 14, 2021

Dec. 31, 2020

May 01, 2020

Mar. 06, 2020

Nov. 21, 2019

Jul. 15, 2017

Jan. 09, 2012

Jan. 06, 2012

Nov. 30, 2008

Long-Term Debt, Total

$ 222,982,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)

$ 15.92

$ 2.59

$ 2.59

Warrants and Rights Outstanding, Term (Year)

7 years 8 months 26 days

3 years 11 months 12 days

4 years 11 months 12 days

Short-Term Debt, Total

$ 18,816,000

$ 14,586,000

Debt, Long-Term and Short-Term, Combined Amount, Total

222,982,000

188,767,000

Other Long-Term Debt, Noncurrent

11,876,000

12,038,000

Stock Issued Under Fuels Revolving Line [Member]

Stock Issued During Period, Shares, New Issues (in shares)

100,000

Third Eye Capital [Member] | Five Year Warrants in Connection With New Credit Facility [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)

50,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)

$ 10.20

Third Eye Capital [Member] | Ten Year Warrants in Connection With New Credit Facility [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)

250,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)

$ 20

AAFK [Member] | Warrants in Connection With Subordinated Notes [Member]

Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)

$ 0.01

$ 0.01

$ 0.01

Warrants and Rights Outstanding, Term (Year)

2 years

2 years

2 years

Class of Warrant or Right, Issued (in shares)

113,000

113,000

Revolving Credit Facility [Member]

Repayments of Long-Term Lines of Credit

$ 16,000,000

Property Taxes Payment

6,100,000

Revolving Credit Facility [Member] | GAFI [Member]

Line of Credit Facility, Maximum Borrowing Capacity

$ 10,000,000

Revolving Credit Facility [Member] | Prime Rate [Member] | GAFI [Member] | Minimum [Member]

Debt Instrument, Basis Spread on Variable Rate

7.75%

Revolving Credit Facility [Member] | Prime Rate [Member] | GAFI [Member] | Maximum [Member]

Debt Instrument, Basis Spread on Variable Rate

12%

Capital Revolving Credit Facility Fuels And Carbon Lines [Member] | GAFI and ACCI [Member]

Line of Credit Facility, Maximum Borrowing Capacity

100,000,000

Fuels Revolving Line [Member] | GAFI [Member]

Line of Credit Facility, Maximum Borrowing Capacity

50,000,000

Carbon Revolving Line [Member] | ACCI [Member]

Line of Credit Facility, Maximum Borrowing Capacity

$ 50,000,000

Third Eye Capital [Member]

Payments of Financing Costs, Total

$ 100,000

Third Eye Capital [Member] | Mr. McAfee [Member]

Net Amount at Risk by Product and Guarantee, Net Amount at Risk

8,000,000

Third Eye Capital [Member] | Revolving Credit Facility [Member]

Debt Instrument, Face Amount

$ 18,000,000

Third Eye Capital [Member] | Revolving Credit Facility [Member] | AAFK [Member]

Long-Term Debt, Total

57,900,000

Debt Issuance Costs, Net, Total

$ 1,100,000

Third Eye Capital [Member] | Revolving Credit Facility [Member] | Prime Rate [Member]

Debt Instrument, Interest Rate, Stated Percentage

20%

Debt Instrument, Basis Spread on Variable Rate

13.75%

Third Eye Capital [Member] | Acquisition Term Notes [Member]

Debt Instrument, Face Amount

$ 15,000,000

Third Eye Capital [Member] | Reserve Liquidity Facility [Member]

Debt Instrument, Interest Rate, Stated Percentage

30%

Long-Term Debt, Total

$ 0

Line of Credit Facility, Current Borrowing Capacity

$ 40,000,000

Term Loan [Member] | GAFI [Member]

Debt Instrument, Face Amount

$ 15,000,000

Debt Instrument, Interest Rate, Stated Percentage

10%

Term Loan [Member] | Third Eye Capital [Member]

Debt Instrument, Face Amount

7,200,000

Revenue Participation Term Notes [Member] | Third Eye Capital [Member]

Debt Instrument, Face Amount

$ 10,000,000

Debt Instrument, Interest Rate, Stated Percentage

5%

Revenue Participation Term Notes [Member] | Third Eye Capital [Member] | AAFK [Member]

Long-Term Debt, Total

$ 11,900,000

Debt Issuance Costs, Net, Total

92,000

Short-term Credit Facility for Working Capital [Member]

Debt, Long-Term and Short-Term, Combined Amount, Total

$ 2,713,000

0

Short-term Credit Facility for Working Capital [Member] | Third Eye Capital [Member]

Proceeds from Lines of Credit, Total

$ 2,100,000

$ 600,000

$ 700,000

Debt Instrument, Interest Rate, Stated Percentage

14%

Amendment No. 19 [Member] | Third Eye Capital [Member]

Debt Instrument, Fee Amount

$ 100,000

Debt Instrument, Extension Fee, Percent of Note Indebtedness

1%

Amendment No. 20 [Member] | Third Eye Capital [Member]

Debt Instrument, Fee Amount

$ 300,000

Debt Instrument, Extension Fee, Percent of Note Indebtedness

1%

Debt Instrument, Restrictive Covenants

$100,000

Amendment No. 21 [Member] | Third Eye Capital [Member]

Debt Instrument, Fee Amount

$ 100,000

Amendment No. 22 [Member] | Third Eye Capital [Member]

Debt Instrument, Fee Amount

$ 100,000

Amendment No. 23 [Member] | Third Eye Capital [Member]

Debt Instrument, Fee Amount

$ 100,000

Amendment No. 24 [Member] | Third Eye Capital [Member]

Debt Instrument, Fee Amount

$ 300,000

Debt Instrument, Extension Fee, Percent of Note Indebtedness

1%

Reserve Liquidity Facility [Member] | Third Eye Capital [Member]

Debt Instrument, Face Amount

$ 18,000,000

Line of Credit Facility, Maximum Borrowing Capacity

$ 40,000,000

$ 70,000,000

Debt Instrument, Non-refundable Standby Fee, Percent of Difference Between Principal Amount and the Commitment

2%

Non Refundable Fees

$ 500,000

Reserve Liquidity Facility Paid Monthly in Arrears [Member] | Third Eye Capital [Member]

Debt Instrument, Interest Rate, Stated Percentage

30%

Reserve Liquidity Facility if Event of Default Occurred and Continues [Member] | Third Eye Capital [Member]

Debt Instrument, Interest Rate, Stated Percentage

40%

Term Notes [Member] | Third Eye Capital [Member]

Debt Instrument, Interest Rate, Stated Percentage

14%

Long-Term Debt, Total

$ 7,100,000

Debt Issuance Costs, Net, Total

52,000

Acquisition Term Notes [Member] | Third Eye Capital [Member] | Aemetis Facility Keyes, Inc. [Member]

Long-Term Debt, Total

26,500,000

Debt Issuance Costs, Net, Total

167,000

Debt Instrument, Redemption Fee

$ 7,500,000

Acquisition Term Notes [Member] | Third Eye Capital [Member] | Prime Rate [Member]

Debt Instrument, Basis Spread on Variable Rate

10.75%

17%

Term Notes, Revolving Credit Facility and Acquisition Term Notes [Member] | Third Eye Capital [Member]

Debt Instrument, Fee, Percent of Carrying Value of Debt

1%

Debt Instrument, Fee, Amount Allowed to be Paid in Cash, Percent

50%

Debt Instrument, Fee, Amount Allowed to be Added to Debt Outstanding, Percent

50%

Term Loan and Revolving Loan [Member] | GAFI [Member]

Debt Instrument, Fee Amount

$ 500,000

Fuels Revolving Line [Member] | GAFI [Member]

Debt Instrument, Interest Rate, Stated Percentage

10%

Fuels Revolving Line [Member] | Prime Rate [Member] | GAFI [Member]

Debt Instrument, Basis Spread on Variable Rate

6%

Carbon Revolving Line [Member] | GAFI [Member]

Long-Term Debt, Total

$ 25,100,000

Debt Issuance Costs, Net, Total

1,700,000

Carbon Revolving Line [Member] | ACCI [Member]

Debt Instrument, Interest Rate, Stated Percentage

8%

Long-Term Debt, Total

22,500,000

Debt Issuance Costs, Net, Total

2,600,000

Carbon Revolving Line [Member] | Prime Rate [Member] | ACCI [Member]

Debt Instrument, Basis Spread on Variable Rate

4%

Cilion Shareholder Seller Notes Payable [Member]

Debt Instrument, Interest Rate, Stated Percentage

3%

Debt, Long-Term and Short-Term, Combined Amount, Total

6,769,000

6,619,000

Cilion Shareholder Seller Notes Payable [Member] | Aemetis Facility Keyes, Inc. [Member]

Long-Term Debt, Total

6,800,000

Subordinated Notes [Member] | AAFK [Member]

Debt Instrument, Fee Amount

$ 2,500,000

$ 900,000

Debt Instrument Fee Rate

10%

Debt Extension Fee, Percentage

10%

Short-Term Debt, Total

15,200,000

14,300,000

Subordinated Notes 1 [Member]

Debt, Long-Term and Short-Term, Combined Amount, Total

15,226,000

14,304,000

Subordinated Notes 1 [Member] | AAFK [Member]

Debt Instrument, Face Amount

$ 90,000

Debt Instrument, Cash Extension Fee

$ 90,000

Subordinated Notes 2 [Member] | AAFK [Member]

Debt Instrument, Face Amount

$ 250,000

Debt Instrument, Cash Extension Fee

$ 250,000

EB5 Phase I Notes [Member]

Debt Instrument, Face Amount

$ 500,000

Long-Term Debt, Total

36,600,000

Debt Instrument, Term (Year)

4 years

Debt Instrument, Convertible, Conversion Price (in dollars per share)

$ 30

Debt Instrument, Amount Released From Escrow

35,500,000

Debt Instrument, Amount Remaining Funded to Escrow

500,000

Principal Amount

37,000,000

EB5 Phase I Notes [Member] | Minimum [Member]

Debt Instrument, Investment Raised Per Investor

$ 500,000

EB5 Phase I Funding [Member]

Debt Instrument, Face Amount

$ 36,000,000

EB5 Phase I Funding [Member] | Maximum [Member]

Debt Instrument, Face Amount

$ 36,000,000

EB5 Phase II Notes [Member]

Debt Instrument, Interest Rate, Stated Percentage

3%

Debt Instrument, Amount Remaining Funded to Escrow

46,800,000

Debt Instrument, Principal Amount Sold

4,000,000

Debt, Long-Term and Short-Term, Combined Amount, Total

4,200,000

EB5 Phase II Notes [Member] | Minimum [Member]

Debt Instrument, Minimum Investment Raised Per Investor

$ 500,000

EB5 Phase II Notes [Member] | Maximum [Member]

Debt Instrument, Minimum Investment Raised Per Investor

$ 900,000

Debt Instrument, Investment Raised Per Investor

900,000

Aggregate Principal Amount

$ 50,800,000

Secunderabad Oils [Member]

Debt Instrument, Interest Rate, Stated Percentage

18%

14.75%

Long-Term Debt, Total

0

$ 0

First Priority Lien on Assets in Return, Percentage of Monthly Net Operating Profit

30%

Debt Instrument, Fair Value Disclosure, Total

$ 2,300,000

Debt Agreement, Maximum Borrowing Capacity

$ 1,880,000

Leo Edibles & Fats Limited [Member]

Debt Instrument, Interest Rate, Stated Percentage

18%

Debt Agreement, Maximum Borrowing Capacity

$ 1,270,000

Secunderabad Oils and Leo Edibles & Fats Limited [Member]

Short-Term Debt, Total

2,700,000

Construction Loan Agreement [Member] | Subsequent Event [Member]

Debt Instrument, Interest Rate, Stated Percentage

5.95%

Debt Agreement, Maximum Borrowing Capacity

$ 25,000,000

Usda Annual Renewal Fee

0.25%

Financing Agreement For Capital Expenditures [Member]

Debt Instrument, Face Amount

5,700,000

Short-Term Debt, Total

900,000

Other Long-Term Debt, Noncurrent

$ 5,100,000

Note 4 - Debt- Schedule of Debt

Note 4 - Debt- Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Total debt	$ 222,982	$ 188,767
Total debt	222,982	188,767
Less current portion of debt	29,020	22,778
Total long term debt	193,962	165,989
Third Eye Capital Term Notes [Member]
Total debt	7,113	7,095
Total debt	7,113	7,095
Third Eye Capital Revolving Credit Facility [Member]
Total debt	57,950	75,980
Total debt	57,950	75,980
Third Eye Capital Revenue Participation Term Notes [Member]
Total debt	11,939	11,915
Total debt	11,939	11,915
Third Eye Capital Acquisition Term Notes [Member]
Total debt	26,521	26,461
Total debt	26,521	26,461
Third Eye Capital Fuels Revolving Line [Member]
Total debt	25,080	0
Total debt	25,080	0
Third Eye Capital Carbon Revolving Line [Member]
Total debt	22,484	0
Total debt	22,484	0
Cilion Shareholder Seller Notes Payable [Member]
Total debt	6,769	6,619
Total debt	6,769	6,619
Subordinated Notes 1 [Member]
Total debt	15,226	14,304
Total debt	15,226	14,304
EB-5 Promissory Notes [Member]
Total debt	41,204	40,692
Total debt	41,204	40,692
Term Loan On Equipment Purchase [Member]
Total debt	5,983	5,701
Total debt	5,983	5,701
Short-term Credit Facility for Working Capital [Member]
Total debt	2,713	0
Total debt	$ 2,713	$ 0

Note 4 - Debt - Maturities of L

Note 4 - Debt - Maturities of Long-term Debt (Details) $ in Thousands	Sep. 30, 2022 USD ($)
2023	$ 29,020
2024	136,757
2025	32,240
2026	28,612
2027	985
There after	1,136
Total debt	228,750
Debt issuance costs	(5,768)
Total debt, net of debt issuance costs	$ 222,982

Note 5 - Commitments and Cont_3

Note 5 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	May 06, 2022	Mar. 03, 2022	Dec. 31, 2021	Jul. 24, 2019
Lease Term (Year)				15 years
Accrual for Taxes Other than Income Taxes, Current	$ 1,028			$ 1,028			$ 6,100	$ 6,830
Estimated Litigation Liability, Current	0			0				$ 6,200	$ 6,200
Settlement Agreement Amount						$ 4,800
Gain (Loss) Related to Litigation Settlement	$ 0	$ 1,400	$ 0	$ 1,400	$ 0

Note 5 - Commitments and Cont_4

Note 5 - Commitments and Contingencies - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating lease expense	$ 159	$ 204	$ 506	$ 612
Short term lease expense	44	28	146	138
Variable lease expense	23	30	68	84
Total operating lease cost	226	262	720	834
Amortization of right-of-use assets	26	58	115	168
Interest on lease liabilities	98	20	217	61
Total finance lease cost	124	78	332	229
Operating cash flows used in operating leases	184	179	522	519
Operating cash flows used in finance leases	98	20	216	61
Financing cash flows used in finance leases	$ 132	$ 126	$ 314	$ 373

Note 5 - Commitments and Cont_5

Note 5 - Commitments and Contingencies - Non-cash Flow Information Related to Rou Asset and Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accretion of the lease liability	$ 83	$ 93	$ 262	$ 288
Amortization of right-of-use assets	$ 76	$ 111	$ 244	$ 324
Operating leases (in years) (Year)	5 years 7 months 6 days		5 years 7 months 6 days
Finance leases (in years) (Year)	14 years 2 months 12 days		14 years 2 months 12 days
Operating leases	14%		14%
Finance leases	13.20%		13.20%

Note 5 - Commitments and Cont_6

Note 5 - Commitments and Contingencies - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Operating lease right-of-use assets	$ 2,227	$ 2,462
Current portion of operating lease liability	267	260
Operating lease liability	2,120	2,318
Total operating lease liabilities	2,387	2,578
Property and equipment, at cost	3,045	2,317
Accumulated depreciation	(79)	(376)
Property and equipment, net	2,966	1,941
Other current liability	118	550
Other long term liabilities	2,854	720
Total finance lease liabilities	$ 2,972	$ 1,270

Note 5 - Commitments and Cont_7

Note 5 - Commitments and Contingencies - Maturities of Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
2023, Operating leases	$ 572
2023, Finance leases	479
2024, Operating leases	586
2024, Finance leases	204
2025, Operating leases	603
2025, Finance leases	176
2026, Operating leases	622
2026, Finance leases	145
2027, Operating leases	641
2027, Finance leases	145
There after, Operating leases	442
There after, Finance leases	11,000
Total lease payments, Operating leases	3,466
Total lease payments, Finance leases	12,149
Less imputed interest, Operating leases	(1,079)
Less imputed interest, Finance leases	(9,177)
Total operating lease liabilities	2,387	$ 2,578
Total finance lease liabilities	$ 2,972	$ 1,270

Note 5 - Commitments and Cont_8

Note 5 - Commitments and Contingencies - Lease Income (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Lease income	$ 804	$ 0

Note 5 - Commitments and Cont_9

Note 5 - Commitments and Contingencies - Future Minimum Lease Payments (Details) $ in Thousands	Sep. 30, 2022 USD ($)
2023	$ 858
2024	643
2025	521
2026	474
2027	474
There after	1,184
Total future lease commitments	$ 4,154

Note 6 - Aemetis Biogas LLC, _2

Note 6 - Aemetis Biogas LLC, Series A Preferred Financing and Variable Interest Entity (Details Textual) - USD ($)			3 Months Ended	9 Months Ended	12 Months Ended
	Aug. 08, 2022	Dec. 20, 2018	Mar. 31, 2021	Sep. 30, 2022	Dec. 31, 2021
Series A Preferred Unit, Current				$ 109,400,000	$ 3,200,000
Liabilities, Other than Long-Term Debt, Noncurrent, Total				0	$ 45,000,000
Total Assets of ABGL Company				67,200,000
Series A Preferred Units Value				$ 109,400,000
Carbon Revolving Line [Member]
Repayments of Debt	$ 7,300,000
Extinguishment of Debt, Gain (Loss), Net of Tax	(49,400,000)
Preferred Units Series A [Member]
Common Units Authorized (in shares)		11,000,000
Common Units Issued (in shares)		6,000,000
Preferred Unit Dividend Rate Per Dollar Amount (in dollars per share)		$ 0.50
Conversion of Stock, Shares Issued (in shares)		1,200,000		5,000,000
Maximum Number of Shares (in shares)		5,000,000
Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value per Unit (in dollars per share)		$ 15
Free Cash Flow Generated by ABGL		75%		100%
Redeemable Noncontrolling Interest Equity Redemption Value, Total		$ 90,000,000
Fees and Commission Transfer Agent		900,000
Debt Instrument, Collateral Amount		$ 30,000,000
Preferred Units Issued Value			$ 3,100,000
Preferred Units, Issued (in shares)			626,000
Preferred Units Redeemed, Value				$ 116,000,000
Preferred Units, Initial Fair Value	105,800,000
Preferred Units Series A [Member] | First Tranche [Member]
Preferred Units Issued Value				$ 16,000,000
Preferred Units, Issued (in shares)				3,200,000
Preferred Units Series A [Member] | Second Tranche [Member
Preferred Units Issued Value				$ 14,000,000
Preferred Units, Issued (in shares)				2,800,000
Stock Redeemed or Called During Period, Shares (in shares)				20,000
Preferred Units Redeemed, Value			$ 300,000
Preferred Units Redeemed (in shares)			20,000
Series A Preferred Stocks [Member]
Common Units Issued (in shares)		6,000,000
Common Units Issuance Value (in dollars per share)		$ 5
Proceeds from Issuance of Common Units		$ 30,000,000
Preferred Units Reserved for Future Issuance (in shares)		5,000,000
Preferred Units Series A Redeemable By December 31, 2022 [Member] | ABGL [Member]
Preferred Units Issued Value	116,000,000
Preferred Units Series A Redeemable By September 30, 2022 [Member] | ABGL [Member]
Preferred Units Issued Value	$ 106,000,000

Note 7 - Stock-based Compensa_3

Note 7 - Stock-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended		9 Months Ended	12 Months Ended
	Apr. 29, 2019	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
The 2019 Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)	10 years				10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)	200,000	1,338,000		1,338,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)		369,000	0	1,307,000	1,140,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares (in shares)				2,900,000
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount		$ 12.3		$ 12.3
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)				2 years 3 months 18 days
The 2019 Stock Plan [Member] | Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)				1,300,000
The 2019 Stock Plan [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)					3 years
The 2019 Stock Plan [Member] | Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)				89,000	120,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)				$ 10.92
Amended and Restated 2007 Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)	177,246

Note 7 - Stock-based Compensa_4

Note 7 - Stock-based Compensation - Schedule of Share-based Payment Award (Details) - The 2019 Stock Plan [Member] - $ / shares	3 Months Ended		9 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021	Apr. 29, 2019
Balance, Shares Available for Grant (in shares)			142,000
Balance, Outstanding (in shares)			3,763,000
Balance, Weighted-Average Exercise Price (in dollars per share)			$ 2.29
Authorized, shares (in shares)	1,338,000		1,338,000		200,000
Options Granted, shares (in shares)	(369,000)	0	(1,307,000)	(1,140,000)
Options Granted, shares (in shares)	369,000	0	1,307,000	1,140,000
Options Granted, Weighted-Average Exercise Price (in dollars per share)			$ 10.97
Exercised, shares (in shares)			(294,000)
Exercised, Weighted-Average Exercise Price (in dollars per share)			$ 0.93
Forfeited/expired, shares (in shares)			67,000
Forfeited/expired, shares (in shares)			(67,000)
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share)			$ 11.44
Balance, Shares Available for Grant (in shares)	151,000		151,000	142,000
Balance, Outstanding (in shares)	4,709,000		4,709,000	3,763,000
Balance, Weighted-Average Exercise Price (in dollars per share)	$ 4.65		$ 4.65	$ 2.29
Restricted Stock [Member]
RSAs Granted, shares (in shares)			(89,000)	(120,000)

Note 7 - Stock-based Compensa_5

Note 7 - Stock-based Compensation - Fair Value Assumptions (Details) - The 2019 Stock Plan [Member] - $ / shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Dividend-yield	0%	0%
Risk-free interest rate	2.03%	0.83%
Expected volatility	117.21%	100.47%
Expected life (years) (Year)	7 years	6 years 7 months 2 days
Market value per share on grant date (in dollars per share)	$ 10.97	$ 5.30
Fair value per option on grant date (in dollars per share)	$ 9.71	$ 4.68

Note 8 - Outstanding Warrants -

Note 8 - Outstanding Warrants - Fair Value Assumptions (Details)	Sep. 30, 2022 yr	Sep. 30, 2021 yr
Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0	0
Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	1.75	0.19
Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	151.41	139.35
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input	3.52	2
Measurement Input, Exercise Price [Member]
Warrants and Rights Outstanding, Measurement Input	10.47	0.01
Measurement Input, Share Price [Member]
Warrants and Rights Outstanding, Measurement Input	11.29	6.83
Fair Value per Warrant on Grant Date [Member]
Warrants and Rights Outstanding, Measurement Input	9.68	6.82

Note 8 - Outstanding Warrants_2

Note 8 - Outstanding Warrants - Schedule of Warrants or Rights (Details) - $ / shares shares in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Outstanding, warrants (in shares)	55	95
Outstanding, Weighted - Average Exercise Price (in dollars per share)	$ 15.92	$ 2.59	$ 2.59
Outstanding, Average Remaining Term in Years (Year)	7 years 8 months 26 days	3 years 11 months 12 days	4 years 11 months 12 days
Granted, warrants (in shares)	527	292
Granted, Weighted - Average Exercise Price (in dollars per share)	$ 10.46	$ 0.01
Exercised, warrants (in shares)	(227)	(332)
Exercised, Weighted - Average Exercise Price (in dollars per share)	$ 0.01	$ 0.32
Outstanding, warrants (in shares)	355	55

Note 9 - Agreements (Details Te

Note 9 - Agreements (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jul. 01, 2022	Dec. 31, 2021
Prepaid Expense, Current, Total	$ 3,671		$ 3,671			$ 5,598
Accounts Receivable, after Allowance for Credit Loss, Current, Total	9,127		9,127			1,574
Marketing Expense	800	$ 700	2,200	$ 2,100
Forward Sales Commitments [Member]
Other Commitment, Total	0	0	0	0
Operating Agreement with Gemini Edibles and Fats India Private Limited [Member]
Debt Agreement, Maximum Borrowing Capacity					$ 12,700
Debt Instrument, Interest Rate, Stated Percentage					12%
Accounts Payable, Total	5,300		5,300			0
J.D. Heiskell [Member]
Prepaid Expense, Current, Total	900		900			4,000
Accounts Receivable, after Allowance for Credit Loss, Current, Total	106	$ 88	106	$ 88
Marketing Partners [Member]
Accounts Receivable, after Allowance for Credit Loss, Current, Total	$ 200		$ 200			$ 1,200

Note 9 - Agreements - Schedule

Note 9 - Agreements - Schedule of Working Capital Agreement Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues	$ 71,831	$ 49,895	$ 189,781	$ 147,586
Accounts receivable, net of allowance for doubtful accounts of $0 and $1,404 as of September 30, 2022 and December 31, 2021, respectively	9,127		9,127		$ 1,574
Accounts payable	32,938		32,938		$ 16,415
J.D. Heiskell [Member]
Accounts receivable, net of allowance for doubtful accounts of $0 and $1,404 as of September 30, 2022 and December 31, 2021, respectively	106	88	106	88
Accounts payable	540	307	540	307
Wet Distiller's Grains Sales [Member] | J.D. Heiskell [Member]
Revenues	13,003	8,919	39,669	30,584
Corn Oil Sales [Member] | J.D. Heiskell [Member]
Revenues	2,917	1,515	8,067	4,252
Corn Purchases [Member] | J.D. Heiskell [Member]
Corn purchases	$ 53,063	$ 39,058	$ 151,425	$ 119,217

Note 10 - Segment Information_2

Note 10 - Segment Information (Details Textual) gal in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022 gal	Sep. 30, 2021
Number of Reportable Segments			3
GallonPerYear (Gallon)			65
California Ethanol [Member]
GallonPerYear (Gallon)			65
California Ethanol [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member]
Number of Major Customers	2	2	2	2
California Ethanol [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Customer One [Member]
Concentration Risk, Percentage	73%	77%	73%	75%
California Ethanol [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Customer Two [Member]
Concentration Risk, Percentage	26%	21%	27%	24%
India Biodiesel [Member]
GallonPerYear (Gallon)			50
India Biodiesel [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Customer One [Member]
Concentration Risk, Percentage		71%	52%	66%
India Biodiesel [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Customer Two [Member]
Concentration Risk, Percentage		23%	23%	16%
India Biodiesel [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Customer Three [Member]
Concentration Risk, Percentage			22%

Note 10 - Segment Information -

Note 10 - Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues	$ 71,831	$ 49,895	$ 189,781	$ 147,586
Gross profit (loss)	(1,104)	(4,785)	(4,403)	(4,747)
Interest expense	7,089	5,548	20,018	17,947
Accretion and other expenses of Series A preferred units	2,774	2,185	5,920	7,928
Capital expenditures	6,413	5,836	28,931	18,771
Depreciation	1,378	1,342	4,039	4,106
Total Assets	198,875	146,979	198,875	146,979	$ 160,831
Intersegment Eliminations [Member]
Revenues	308	355	940	1,090
California Ethanol [Member]
Revenues	60,908	49,832	178,840	146,890
Gross profit (loss)	(3,763)	(4,413)	(6,795)	(4,172)
Interest expense	4,744	5,563	15,258	16,248
Accretion and other expenses of Series A preferred units	0	0	0	0
Capital expenditures	210	749	7,379	1,524
Depreciation	1,023	1,020	3,011	3,122
Total Assets	65,567	69,454	65,567	69,454
California Ethanol [Member] | Intersegment Eliminations [Member]
Revenues	0	0	0	0
Dairy Renewable Natural Gas [Member]
Revenues	0	0	0	0
Gross profit (loss)	(179)	(397)	(454)	(482)
Interest expense	1	3	12	9
Accretion and other expenses of Series A preferred units	2,774	2,185	5,920	7,928
Capital expenditures	3,626	3,111	15,771	10,006
Depreciation	156	145	456	429
Total Assets	65,076	34,769	65,076	34,769
Dairy Renewable Natural Gas [Member] | Intersegment Eliminations [Member]
Revenues	308	355	940	1,090
India Biodiesel [Member]
Revenues	10,923	63	10,941	696
Gross profit (loss)	2,841	47	2,859	(23)
Interest expense	69	0	69	0
Accretion and other expenses of Series A preferred units	0	0	0	0
Capital expenditures	0	21	136	139
Depreciation	161	155	493	513
Total Assets	22,415	11,259	22,415	11,259
India Biodiesel [Member] | Intersegment Eliminations [Member]
Revenues	0	0	0	0
Other Segments [Member]
Revenues	0	0	0	0
Gross profit (loss)	(3)	(22)	(13)	(70)
Interest expense	2,275	(18)	4,679	1,690
Accretion and other expenses of Series A preferred units	0	0	0	0
Capital expenditures	2,577	1,955	5,645	7,102
Depreciation	38	22	79	42
Total Assets	45,817	31,497	45,817	31,497
Other Segments [Member] | Intersegment Eliminations [Member]
Revenues	$ 0	$ 0	$ 0	$ 0

Note 10 - Segment Information_3

Note 10 - Segment Information - Reconciliation of Revenue from Segments to Consolidated (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 71,831	$ 49,895	$ 189,781	$ 147,586
Revenues	(71,831)	(49,895)	(189,781)	(147,586)
Operating Segments [Member]
Revenues	72,139	50,250	190,721	148,676
Revenues	(72,139)	(50,250)	(190,721)	(148,676)
Intersegment Eliminations [Member]
Revenues	308	355	940	1,090
Revenues	$ (308)	$ (355)	$ (940)	$ (1,090)

Note 11 - Related Party Trans_2

Note 11 - Related Party Transactions (Details Textual) - USD ($) $ in Thousands			3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 12, 2022	Nov. 04, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Prepaid Expense, Current, Total			$ 3,671		$ 3,671		$ 5,598
Mr. McAfee [Member]
Accrued Liabilities, Current, Total			0		0		300
Stock Issued During Period, Shares, Issued for Services (in shares)	180,000
Various Board Members [Member]
Share-Based Payment Arrangement, Expense			100	$ 100	300	$ 200
Employment Agreements and Expense Reimbursements [Member] | Mr. McAfee [Member]
Related Party Transaction, Amounts of Transaction					400
Prepayments [Member] | Mr. McAfee [Member]
Related Party Transaction, Amounts of Transaction					200
Prepaid Expense, Current, Total			$ 100		100
Guarantee Fee [Member] | Mr. McAfee [Member]
Related Party Transaction, Amounts of Transaction		$ 400
One-time Guarantee Fee [Member] | Mr. McAfee [Member]
Related Party Transaction, Amounts of Transaction	$ 2,000
Board Compensation Fees [Member] | Various Board Members [Member]
Related Party Transaction, Amounts of Transaction					$ 300		$ 200

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual) - Subsequent Event [Member] - Construction Loan Agreement [Member] $ in Millions	Oct. 04, 2022 USD ($)
Debt Agreement, Maximum Borrowing Capacity	$ 25
Debt Instrument, Interest Rate, Stated Percentage	5.95%
Usda Annual Renewal Fee	0.25%